1 asset in Interdigitating Dendritic Cell Sarcoma
Therapeutic assets addressing Interdigitating Dendritic Cell Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
q702 Interdigitating Dendritic Cell Sarcoma | Mayo Clinic | P1 | CC (43) |